Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Pyxis Oncology (PYXS) Equity Ratio (2024 - 2025)

Pyxis Oncology (PYXS) has disclosed Equity Ratio for 2 consecutive years, with 0.58 as the latest value for Q4 2025.

  • Quarterly Equity Ratio fell 24.04% to 0.58 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 0.58 through Dec 2025, down 24.04% year-over-year, with the annual reading at 0.58 for FY2025, 24.04% down from the prior year.
  • Equity Ratio for Q4 2025 was 0.58 at Pyxis Oncology, down from 0.65 in the prior quarter.
  • The five-year high for Equity Ratio was 0.84 in Q1 2024, with the low at 0.58 in Q4 2025.